Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UT-15C SR in Exercise-Induced Pulmonary Hypertension
NCT01104870Phase 2Completed
- Sponsor
- United Therapeutics Corporation
- Start
- Apr 2010
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of treprostinil in pulmonary hypertension (PH), sponsored by United Therapeutics Corporation. Started Apr 2010; status: completed.
02
Drugs
treprostinil
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01104870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01104870.